Evidence map›Paper›PMID 42165632›Full record

ArticlePharmaceutical biology2026

Sauchinone attenuates UVB-induced photoaging by suppressing oxidative stress and ferroptosis through activation of the Keap1-Nrf2 pathway in dermal fibroblasts.

Xinyi Zhang, Jing Wang, Ying Zhou, Chenye Shen, Minjia Yuan, Qi Li, Wei Li

Abstract read
In one paragraph

Article in Pharmaceutical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xinyi ZhangShanghai Qiran Biotechnology Co., Ltd, Shanghai, PR China.
Jing WangShanghai Qiran Biotechnology Co., Ltd, Shanghai, PR China.
Ying ZhouShanghai Qiran Biotechnology Co., Ltd, Shanghai, PR China.
Chenye ShenShanghai Qiran Biotechnology Co., Ltd, Shanghai, PR China.
Minjia YuanShanghai Qiran Biotechnology Co., Ltd, Shanghai, PR China.
Qi LiShanghai Qiran Biotechnology Co., Ltd, Shanghai, PR China.
Wei LiDepartment of Dermatology, Shanghai Institute of Dermatology, National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextSkin photoaging induced by chronic ultraviolet B (UVB) exposure is primarily driven by oxidative stress. Emerging evidence suggests that ferroptosis contributes to UVB-induced skin damage. Sauchinone, a phenolic lignan derived from

objectiveThis study aimed to investigate the potential photoprotective effects and underlying mechanisms of sauchinone against UVB-induced skin damage in dermal fibroblasts. MATERIALS AND

methodsUVB-induced HFFs were used as an

resultsSauchinone significantly attenuated cellular senescence and ECM degradation in UVB-induced HFFs, as evidenced by reduced SA-β-gal activity and decreased expression of p16 and p21, increased COL1A1 levels, and decreased MMP1 levels. Sauchinone also alleviated oxidative stress by reducing intracellular ROS and MDA levels while restoring GSH content and antioxidant enzyme activity. In addition, sauchinone attenuated ferroptosis-related features, including reduced lipid ROS and Fe DISCUSSION AND

conclusionsOur findings revealed that sauchinone protected fibroblasts against UVB-induced photoaging by inhibiting oxidative stress and ferroptosis, potentially through activation of the Keap1-Nrf2 pathway.

Indexed as

BenzopyransDioxolesFerroptosisOxidative StressSkin AgingUltraviolet RaysAntioxidantsCells, CulturedCellular SenescenceFibroblastsHumansKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Signal TransductionAntioxidantsBenzopyransDioxolesKEAP1 protein, humanKelch-Like ECH-Associated Protein 1NFE2L2 protein, humanNF-E2-Related Factor 2sauchinoneferroptosisKeap1-Nrf2oxidative stressphotoagingSauchinone

Identifiers

PMID42165632
PMCPMC13195707

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.